CatalystWireBeta

Integrated Diagnostics Holdings

IDHC · Main Market · Health Care · mcap £213m · $0.49 (≈37p) 1 open situation →

Beta Briefing, track record and signals & risks are not ready for Integrated Diagnostics Holdings yet.

We follow 960 UK small caps and every one of their announcements – often hundreds per company. 101 companies are already wired into a briefing: browse them.

Timeline · every situation
dots = announcements

Open · 1

Takeover target

Offer for the company

offer

Hena, owned by CEO Dr Hend El-Sherbini and her mother, made a Rule 9 mandatory final cash offer at USD0.50 on 23 June 2026 after buying Elliott's 21.67%. The offer was declared unconditional on 29 July 2026 and closed on 12 August 2026. Hena ended with 56.67%, below the 75% needed for delisting, leaving a 43.33% free float.

Delisting
Needed 75%; Hena is below that threshold, and no delisting is mentioned 11 Sep 2026 ↗
Relationship agreement
None entered into or intended by Bidco
Offer
US$0.50 cash per IDH Share, mandatory final offer announced 23 June 2026 11 Sep 2026 ↗
Acceptances
40,631,301 IDH Shares, about 6.98%, valid at 3.00 p.m. on 28 July 2026 29 Jul 2026 ↗
Bidco holding
329,076,684 shares counted, about 56.60% of issued share capital 29 Jul 2026 ↗
Status
Acceptance Condition was the sole condition; Offer declared unconditional on 29 July 2026 29 Jul 2026 ↗
  1. 13 Aug 2026 update
  2. 23 Jun 2026 offer
Open the full view – chart and every step →

Closed · 2

OverhangElliott Investment Management, L.P. selling down holder sold out · 24 Jun 2026 – 24 Jun 2026 +6% Stake building towards controlHena Holdings Ltd towards control a bid followed · 23 Jun 2026 – 23 Jun 2026 −7%

Company filings. Not investment advice.

Share this quote

Quote card
Post on X WhatsApp Download image

The link opens this announcement with the quote highlighted. Quotes are checked against the original text.

Add a note